| scholarly article | Q13442814 |
| P50 | author | Edward A. Phelps | Q57003780 |
| P2093 | author name string | Andrés J García | |
| Hazel Y Stevens | |||
| Joel D Boerckel | |||
| Kenneth M Dupont | |||
| Robert E Guldberg | |||
| Brent A Uhrig | |||
| Yash M Kolambkar | |||
| P2860 | cites work | Novel regulators of bone formation: molecular clones and activities | Q24297338 |
| Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation | Q24616097 | ||
| Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography | Q24634311 | ||
| Collagen sponges for bone regeneration with rhBMP-2 | Q28185098 | ||
| Bone: formation by autoinduction | Q28251545 | ||
| Clinical applications of recombinant human BMPs: early experience and future development | Q30977277 | ||
| Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies | Q31043540 | ||
| Bioartificial matrices for therapeutic vascularization | Q33734474 | ||
| Synergistic effects of tethered growth factors and adhesion ligands on DNA synthesis and function of primary hepatocytes cultured on soft synthetic hydrogels. | Q33859769 | ||
| A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7 | Q33970526 | ||
| Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. | Q34009606 | ||
| Chemical basis for the histological use of safranin O in the study of articular cartilage | Q34204918 | ||
| An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. | Q34454478 | ||
| The role of growth factors in the repair of bone. Biology and clinical applications. | Q34683755 | ||
| Mechanism for the action of bone morphogenetic proteins and regulation of their activity | Q34805691 | ||
| Bone morphogenetic protein delivery systems | Q34805705 | ||
| Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications | Q34805764 | ||
| A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis | Q35943780 | ||
| Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review | Q36899198 | ||
| Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants. | Q37012773 | ||
| Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). | Q37126334 | ||
| A perspective: engineering periosteum for structural bone graft healing. | Q37176129 | ||
| A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery | Q37205725 | ||
| Solubilized and insolubilized bone morphogenetic protein | Q37327671 | ||
| Homology of bone-inductive proteins from human, monkey, bovine, and rat extracellular matrix | Q37549175 | ||
| Spatiotemporal delivery strategies for promoting musculoskeletal tissue regeneration | Q37571942 | ||
| Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes | Q37682311 | ||
| Graft options in posterolateral and posterior interbody lumbar fusion | Q37772387 | ||
| The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. | Q39234885 | ||
| Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells | Q39835038 | ||
| The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo. | Q39893234 | ||
| Bone morphogenetic protein-2: biology and applications. | Q40966438 | ||
| Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity | Q41211589 | ||
| Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells | Q41251844 | ||
| rBMP represses Wnt signaling and influences skeletal progenitor cell fate specification during bone repair. | Q41811415 | ||
| Polymers for the sustained release of proteins and other macromolecules | Q42102243 | ||
| Preparation of regular sized Ca-alginate microspheres using membrane emulsification method | Q43655127 | ||
| Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein | Q44551921 | ||
| Effect of substrate mechanics on chondrocyte adhesion to modified alginate surfaces | Q44753777 | ||
| The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora | Q44979449 | ||
| Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix | Q46046620 | ||
| Biological effects of rAAV-caAlk2 coating on structural allograft healing. | Q46618116 | ||
| Bone morphogenetic protein | Q47735520 | ||
| Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies | Q48360114 | ||
| Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies | Q48360126 | ||
| Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. | Q51029499 | ||
| Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. | Q51082811 | ||
| Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. | Q51083232 | ||
| Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. | Q51168965 | ||
| A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment. | Q51214211 | ||
| Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. | Q51426324 | ||
| Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. | Q51642521 | ||
| Effect of chondroitin sulfate modification on rhBMP-2 release kinetics from collagen delivery system. | Q51784222 | ||
| Regulating bone formation via controlled scaffold degradation. | Q51807677 | ||
| The Safety of OP-1 for Lumbar Fusion with Decompression - a Canine Study | Q61228498 | ||
| Fractures of allografts. Frequency, treatment, and end-results | Q68843220 | ||
| Carrier systems for bone morphogenetic proteins | Q73145124 | ||
| Delivery systems for BMPs: factors contributing to protein retention at an application site | Q73789377 | ||
| Release from alginate enhances the biological activity of vascular endothelial growth factor | Q77708503 | ||
| Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers | Q78056737 | ||
| Validation of a method for non-invasive in vivo measurement of growth factor release from a local delivery system in bone | Q79961755 | ||
| In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin | Q80268419 | ||
| Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment | Q81379276 | ||
| Biocompatibility and safety of a hybrid core-shell nanoparticulate OP-1 delivery system intramuscularly administered in rats | Q82376663 | ||
| Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release | Q83454449 | ||
| Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures | Q84147862 | ||
| In vivo model for evaluating the effects of mechanical stimulation on tissue-engineered bone repair | Q84232796 | ||
| P433 | issue | 22 | |
| P304 | page(s) | 5241-5251 | |
| P577 | publication date | 2011-04-20 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Effects of protein dose and delivery system on BMP-mediated bone regeneration | |
| P478 | volume | 32 |
| Q38644107 | 3D biomimetic artificial bone scaffolds with dual-cytokines spatiotemporal delivery for large weight-bearing bone defect repair |
| Q98772242 | 3D bioprinting spatiotemporally defined patterns of growth factors to tightly control tissue regeneration |
| Q91869690 | A rapid method for determining protein diffusion through hydrogels for regenerative medicine applications |
| Q42183808 | A silk hydrogel-based delivery system of bone morphogenetic protein for the treatment of large bone defects |
| Q35537743 | A transient cell-shielding method for viable MSC delivery within hydrophobic scaffolds polymerized in situ |
| Q33679554 | Accelerated postero-lateral spinal fusion by collagen scaffolds modified with engineered collagen-binding human bone morphogenetic protein-2 in rats |
| Q40710612 | Accelerating protein release from microparticles for regenerative medicine applications |
| Q90283060 | Anisotropic Cryostructured Collagen Scaffolds for Efficient Delivery of RhBMP-2 and Enhanced Bone Regeneration |
| Q51734259 | Applications of Metals for Bone Regeneration. |
| Q36641581 | Attenuated human bone morphogenetic protein-2-mediated bone regeneration in a rat model of composite bone and muscle injury |
| Q39618660 | BMP9 a possible alternative drug for the recently withdrawn BMP7? New perspectives for (re-)implementation by personalized medicine |
| Q59032489 | Biological, Chemical, and Electronic Applications of Nanofibers |
| Q33721978 | Biomaterial scaffolds for treating osteoporotic bone |
| Q36137494 | Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair |
| Q34025148 | Bone morphogenetic proteins and their antagonists: current and emerging clinical uses |
| Q86506801 | Bone regeneration using a freeze-dried 3D gradient-structured scaffold incorporating OIC-A006-loaded PLGA microspheres based on β-TCP/PLGA |
| Q33660842 | Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle. |
| Q39088959 | Cell-laden hydrogels for osteochondral and cartilage tissue engineering |
| Q64265360 | Chondroitin Sulfate Glycosaminoglycan Scaffolds for Cell and Recombinant Protein-Based Bone Regeneration |
| Q28084738 | Clinical translation of controlled protein delivery systems for tissue engineering |
| Q93137507 | Combinatorial morphogenetic and mechanical cues to mimic bone development for defect repair |
| Q42093221 | Comparative analysis of carrier systems for delivering bone morphogenetic proteins |
| Q41762479 | Comparative stability studies of poly(2-methyl-2-oxazoline) and poly(ethylene glycol) brush coatings |
| Q36005075 | Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration |
| Q34794967 | Constructing the toolbox: Patient-specific genetic factors of altered fracture healing |
| Q46285077 | Controlled release of BMP-2 using a heparin-conjugated carrier system reduces in vivo adipose tissue formation. |
| Q38069892 | Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems |
| Q38068244 | Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery |
| Q39261835 | Covalently grafted BMP-7 peptide to reduce macrophage/monocyte activity: an in vitro study on cobalt chromium alloy. |
| Q37995298 | Delivering bioactive molecules as instructive cues to engineered tissues |
| Q38784521 | Delivery vehicle effects on bone regeneration and heterotopic ossification induced by high dose BMP-2. |
| Q36840091 | Dentin regeneration by stem cells of apical papilla on injectable nanofibrous microspheres and stimulated by controlled BMP-2 release |
| Q84140965 | Design and fabrication of tubular scaffolds via direct writing in a melt electrospinning mode |
| Q45868902 | Development of a Cell-Based Gene Therapy Approach to Selectively Turn Off Bone Formation. |
| Q49196453 | Dose reduction of bone morphogenetic protein-2 for bone regeneration using a delivery system based on lyophilization with trehalose |
| Q37948149 | Dual delivery of an antibiotic and a growth factor addresses both the microbiological and biological challenges of contaminated bone fractures |
| Q34983861 | Effect of cell origin and timing of delivery for stem cell-based bone tissue engineering using biologically functionalized hydrogels |
| Q36707667 | Effects of Recombinant Human Bone Morphogenetic Protein-2 Dose and Ceramic Composition on New Bone Formation and Space Maintenance in a Canine Mandibular Ridge Saddle Defect Model |
| Q47111316 | Effects of rhBMP-2 Loaded Titanium Reinforced Collagen Membranes on Horizontal Bone Augmentation in Dogs |
| Q47175902 | Efficacy of two different demineralised bone matrix grafts to promote bone healing in a critical-size-defect: a radiological, histological and histomorphometric study in rat femurs |
| Q26852370 | Engineering the matrix microenvironment for cell delivery and engraftment for tissue repair |
| Q48960013 | Enhanced Mandibular Bone Repair by Combined Treatment of Bone Morphogenetic Protein 2 and Small-Molecule Phenamil. |
| Q47335168 | Enhanced in vivo retention of low dose BMP-2 via heparin microparticle delivery does not accelerate bone healing in a critically sized femoral defect |
| Q45066843 | Evaluation of osteogenic inductivity of a novel BMP2-mimicking peptide P28 and P28-containing bone composite |
| Q92446575 | Exploratory Full-Field Strain Analysis of Regenerated Bone Tissue from Osteoinductive Biomaterials |
| Q37995448 | Growth factor delivery: how surface interactions modulate release in vitro and in vivo |
| Q38261985 | Growth factors in orthopaedic surgery: demineralized bone matrix versus recombinant bone morphogenetic proteins |
| Q92543987 | Heparin-mediated delivery of bone morphogenetic protein-2 improves spatial localization of bone regeneration |
| Q35463054 | How does the pathophysiological context influence delivery of bone growth factors? |
| Q46010521 | Human Bone Progenitor Cells for Clinical Application: What Kind of Immune Reaction Does Fetal Xenograft Tissue Trigger in Immunocompetent Rats? |
| Q35912357 | Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft |
| Q28547838 | In silico Mechano-Chemical Model of Bone Healing for the Regeneration of Critical Defects: The Effect of BMP-2 |
| Q34293509 | In vivo bioluminescent tracking of mesenchymal stem cells within large hydrogel constructs |
| Q38176443 | Initiation and early control of tissue regeneration - bone healing as a model system for tissue regeneration |
| Q34111594 | Inkjet-based biopatterning of SDF-1β augments BMP-2-induced repair of critical size calvarial bone defects in mice. |
| Q26824921 | Investigation of potential injectable polymeric biomaterials for bone regeneration |
| Q43419291 | Local application of an ibandronate/collagen sponge improves femoral fracture healing in ovariectomized rats. |
| Q38186661 | Local strategies to prevent and treat osteoporosis |
| Q35623313 | Longitudinal in vivo evaluation of bone regeneration by combined measurement of multi-pinhole SPECT and micro-CT for tissue engineering |
| Q47221325 | Low-dose BMP-2 and MSC dual delivery onto coral scaffold for critical-size bone defect regeneration in sheep |
| Q33575512 | Low-dose bone morphogenetic protein-2/stromal cell-derived factor-1β cotherapy induces bone regeneration in critical-size rat calvarial defects. |
| Q35216984 | Mechanical regulation of vascular growth and tissue regeneration in vivo |
| Q34911047 | Microcomputed tomography: approaches and applications in bioengineering |
| Q41173391 | Microparticle entrapment for drug release from porous-surfaced bone implants |
| Q45783901 | Mineralized tissue formation by bone morphogenetic protein-7-transfected pulp stem cells |
| Q40447649 | Modern Approaches to Studies of New Osteogenic Biomaterials on the Model of Regeneration of Critical-Size Cranial Defects in Rats. |
| Q38157926 | Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. |
| Q59329742 | Optimizing bone wound healing using BMP2 with absorbable collagen sponge and Talymed nanofiber scaffold |
| Q42238675 | Osteoinductivity Assessment of BMP-2 Loaded Composite Chitosan-Nano-Hydroxyapatite Scaffolds in a Rat Muscle Pouch |
| Q34160953 | Oxidized alginate hydrogels for bone morphogenetic protein-2 delivery in long bone defects. |
| Q57998789 | Polycyanoacrylate porous material for bone tissue substitution |
| Q30389472 | Pre-clinical characterization of tissue engineering constructs for bone and cartilage regeneration |
| Q47296936 | Prolonged delivery of BMP-2 by a non-polymer hydrogel for bone defect regeneration. |
| Q64100410 | Protein diffusion from microwells with contrasting hydrogel domains |
| Q92547358 | Recapitulating bone development through engineered mesenchymal condensations and mechanical cues for tissue regeneration |
| Q41963604 | Reduction of Adipose Tissue Formation by the Controlled Release of BMP-2 Using a Hydroxyapatite-Coated Collagen Carrier System for Sinus-Augmentation/Extraction-Socket Grafting. |
| Q40272007 | Release of bio-active dentine extracellular matrix components by histone deacetylase inhibitors (HDACi). |
| Q37609521 | RhBMP-2 loaded 3D-printed mesoporous silica/calcium phosphate cement porous scaffolds with enhanced vascularization and osteogenesis properties |
| Q58689174 | Scaffolds for Growth Factor Delivery as Applied to Bone Tissue Engineering |
| Q36162174 | Self-assembling nanoparticles for intra-articular delivery of anti-inflammatory proteins |
| Q38858127 | Skeletal Myoblast-Seeded Vascularized Tissue Scaffolds in the Treatment of a Large Volumetric Muscle Defect in the Rat Biceps Femoris Muscle |
| Q39028377 | Spatial patterning of BMP-2 and BMP-7 on biopolymeric films and the guidance of muscle cell fate |
| Q64055476 | Spatially-offset Raman spectroscopy for monitoring mineralization of bone tissue engineering scaffolds: feasibility study based on phantom samples |
| Q37420513 | Stiffness-dependent cellular internalization of matrix-bound BMP-2 and its relation to Smad and non-Smad signaling. |
| Q89995936 | Stimuli-Responsive Delivery of Growth Factors for Tissue Engineering |
| Q39122306 | Strategies of enhancing bone regenerate formation in distraction osteogenesis |
| Q36106613 | Studies of bone morphogenetic protein-based surgical repair |
| Q37191089 | Substrate Modulus Regulates Osteogenic Differentiation of Rat Mesenchymal Stem Cells through Integrin β1 and BMP Receptor Type IA. |
| Q51233781 | Surface delivery of tunable doses of BMP-2 from an adaptable polymeric scaffold induces volumetric bone regeneration. |
| Q34973974 | Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats |
| Q34377496 | Synthesis and characterization of UPPE-PLGA-rhBMP2 scaffolds for bone regeneration |
| Q41829310 | TGF-β1 conjugated chitosan collagen hydrogels induce chondrogenic differentiation of human synovium-derived stem cells |
| Q90604024 | Testing a novel nanofibre scaffold for utility in bone tissue regeneration |
| Q92090591 | The Effects of Age and Dose on Gene Expression and Segmental Bone Defect Repair After BMP-2 Delivery |
| Q57146234 | The Interaction of BMP2-Induced Defect Healing in Rat and Fixator Stiffness Modulates Matrix Alignment and Contraction |
| Q53386021 | The effect of the delivery carrier on the quality of bone formed via bone morphogenetic protein-2. |
| Q55333479 | The modulation of stem cell behaviors by functionalized nanoceramic coatings on Ti-based implants. |
| Q38327456 | The use of BMP-2 and screw exchange in the treatment of scaphoid fracture non-union |
| Q39032548 | Tissue engineering scaffold for sequential release of vancomycin and rhBMP2 to treat bone infections |
| Q37380695 | Tooth-derived bone graft material |
| Q47147858 | Tuning Alginate Bioink Stiffness and Composition for Controlled Growth Factor Delivery and to Spatially Direct MSC Fate within Bioprinted Tissues |
| Q37893542 | Use and efficacy of bone morphogenetic proteins in fracture healing. |
| Q28564040 | Use of OP-1 (rhBMP-7) in posterolateral lumbar arthrodesis |
| Q37109219 | Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo |
| Q38182349 | Vascularization strategies for bone regeneration |
| Q90198660 | Wireless sensor enables longitudinal monitoring of regenerative niche mechanics during rehabilitation that enhance bone repair |
Search more.